Organ functions of the human yolk sac revealed
The role of the human yolk sac in supporting early embryonic development and the first wave of the prenatal immune system has been mapped in a study published in Science.
Researchers from the Wellcome Sanger...
Tackling critical health challenges in space
New research by The University of Manchester will enhance the power of bioprinting technology, opening doors to transform advances in medicine and address critical health challenges faced by astronauts during space missions.
Bioprinting involves using...
Key gene blocks the ‘spillover’ of avian flu to humans
Understanding the genetic make-up of currently circulating avian flu strains may offer one of the best lines of defence against widespread human transmission.
This is according to new research which has found a key human...
Depression up, Covid-19 down in disease study list
Depression is now one of the top five most studied disease areas in clinical development, according to new global analysis by Phesi.
The mid-year analysis of all this year’s trials to date reveals that Covid-19...
Supporting Drug Discovery: A Journey into the World of Inspiralis Limited
I. Introduction
As drug discovery continues to evolve, innovative tools and resources are essential for unlocking the potential of emerging compounds, and that’s where Inspiralis Limited comes in. As a leading biotech company specializing in...
Why Norwich is a UK hotspot for innovation in modern industrial biotechnology
The publication of a new study commissioned by the Government Office for Science (GOS) earlier this year highlighted the East of England as a hotspot for biotechnology adoption and commercialisation. The study titled ‘Life...
Work begins on £62m expansion of NETPark
Work is underway on the exciting £62M expansion of one of the UK’s premier science parks.
Led by Business Durham and funded by Durham County Council, the development of Phase 3 of the North East...
The promise of immuno-oncology: An R&D perspective
Dr Robin Knight, CEO and co-founder, IN-PART, discusses emerging cancer immunotherapies.
Cancer immunotherapy, also referred to as immuno-oncology, is gaining traction. New treatments are becoming available all the time, and they’re showing incredible promise in...
Do you want to unlock significant costs savings, without putting jobs at risk?
With over 30-years of experience, we are experts at significantly reducing your costs with our unique and proven propriety data and expertise. SRM is the UK and Europe’s best kept secret: there’s no one...
Taking cell AND gene therapy to the next level
The cell and gene therapy (CGT) sector urgently needs common standards. Open dialogue will help achieve the best outcomes for developers, manufacturers and - most importantly - the patients. Aloysius Chong, Project Director at...
New ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
An extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification.
Pluripotent stem cell technology provider for drug discovery, Axol Bioscience Ltd (Axol), has signed an exclusive agreement...
UK life sciences raised over £10.5bn in investment between 2020 and 2022
UK life sciences companies raised more this impressive sum, driven by the UK’s advanced research and development capabilities.
The total amount of VC investment in the sector was more than that in Germany, France and...
Software untangles genetics linked to common ancestry
Aston University has worked with international partners to develop a software package which helps scientists answer key questions about genetic factors associated with shared characteristics among different species.
Called CALANGO (comparative analysis with annotation-based genomic...
All hands to the pumps – how bacteria evolve resistance to antibiotics
Bacteria can rapidly evolve resistance to antibiotics by adapting special pumps to flush them out of their cells, say researchers from the Quadram Institute and University of East Anglia.
The findings, published in the journal...
Leukaemia diagnosis and treatment on brink of huge change
UK scientists hope they can learn to better predict leukaemia (blood cancer) occurrence, and develop improved drug screening pathways to treat the disease, with funding worth £12million.
Two projects – led by the University of...
AI disease testing platform developed for military use
Drive to improve the UK’s capability to manage and treat personnel affected by virulent infectious agents.
A portable prototype of an AI-powered disease testing platform for the military is being funded by the Defence and...